Cannabidiol and neurodegeneration: From molecular mechanisms to clinical benefits

大麻酚 神经退行性变 医学 神经科学 疾病 精神科 生物 大麻 内科学
作者
Saurabh Kumar Jha,Vinod Kumar Nelson,Punna Rao Suryadevara,Siva Prasad Panda,Chitikela P. Pullaiah,Mohana Vamsi Nuli,Mehnaz Kamal,Mohd Imran,Saijyothi Ausali,Mosleh Mohammad Abomughaid,Rashi Srivastava,Rahul Deka,Pingal Pritam,Neha Gupta,Harishankar Shyam,Indrakant K. Singh,Bindhy Wasini Pandey,Saikat Dewanjee,Niraj Kumar Jha,Seid Mahdi Jafari
出处
期刊:Ageing Research Reviews [Elsevier BV]
卷期号:100: 102386-102386 被引量:25
标识
DOI:10.1016/j.arr.2024.102386
摘要

Neurodegenerative disorders (NDs) such as Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, and amyotrophic lateral sclerosis are severe and life-threatening conditions in which significant damage of functional neurons occurs to produce malfunction of psycho-motor functions. NDs are an important cause of death in the elderly population worldwide. These disorders are commonly associated with the progression of age, oxidative stress, and environmental pollutants, which are the major etiological factors. Abnormal aggregation of specific proteins such as α-synuclein, amyloid-β, huntingtin, and tau, and accumulation of its associated oligomers in neurons are the hallmark pathological features of NDs. Existing therapeutic options for NDs are only symptomatic relief and do not address root-causing factors, such as protein aggregation, oxidative stress, and neuroinflammation. Cannabidiol is a non-psychotic natural cannabinoid obtained from Cannabis sativa that possesses multiple pharmacological actions, including antioxidant, anti-inflammatory, and neuroprotective effects in various NDs and other neurological disorders both in vitro and in vivo. Cannabidiol has gained attention as a promising therapeutic drug candidate for the management of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, by inhibiting protein aggregation, free radicals, and neuroinflammation. In parallel, CBD has shown positive results in other neurological disorders, such as epilepsy, depression, schizophrenia, and anxiety, as well as adjuvant treatment with existing standard therapeutic agents. Hence, the present review focuses on exploring the possible molecular mechanisms in controlling various neurological disorders as well as its clinical applications in NDs including epilepsy, depression and anxiety. In this way, the current review will serve as a standalone reference for the researchers working in this area.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
七听发布了新的文献求助20
刚刚
叮了个当发布了新的文献求助10
刚刚
个高视野远完成签到,获得积分10
1秒前
胡庆余堂小洋参完成签到,获得积分10
1秒前
悦耳的以蓝完成签到 ,获得积分10
1秒前
1秒前
问夏发布了新的文献求助30
2秒前
2秒前
斯文败类的应助被默默的幻枫采纳,获得10
3秒前
大个的应助被岷瓮采纳,获得10
3秒前
科研通AI6.2的应助被shitaocameron采纳,获得10
3秒前
4秒前
nn发布了新的文献求助10
4秒前
4秒前
4秒前
4秒前
田様的应助被Sledge采纳,获得10
4秒前
liwanr完成签到,获得积分10
5秒前
5秒前
OK的应助被大胆初丹采纳,获得200
5秒前
CodeCraft的应助被ppppppppx采纳,获得10
5秒前
汉堡包的应助被洛水采纳,获得10
5秒前
7秒前
谭谨川完成签到,获得积分10
8秒前
8秒前
8秒前
wh完成签到,获得积分10
9秒前
谷槐完成签到,获得积分10
9秒前
9秒前
Mr_Huang发布了新的文献求助10
10秒前
10秒前
嘿1111完成签到,获得积分10
10秒前
10秒前
得鹿梦鱼完成签到,获得积分10
10秒前
10秒前
11秒前
丁丁当当发布了新的文献求助100
11秒前
nonoke完成签到 ,获得积分10
11秒前
宇文孜胥完成签到,获得积分10
12秒前
Nuyoah发布了新的文献求助10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Aspects of Post-SPE Phonology 2000
Recombinant human Type III collagen with native-like assembly and real biomaterial performance 1000
CLSI VET01S Ed7 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals 1000
Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals 888
Rosenblum, Global Change Biology 800
Holistic Discourse Analysis, Second Edition by Robert E. Longacre (2012-09-10) 666
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 物理 有机化学 化学工程 内科学 生物化学 复合材料 催化作用 心理学 细胞生物学 无机化学 电极 光电子学 人工智能
热门帖子
关注 科研通微信公众号,转发送积分 7874151
求助须知:如何正确求助?哪些是违规求助? 9390006
关于积分的说明 20779626
捐赠科研通 7475624
什么是DOI,文献DOI怎么找? 3351974
关于科研通互助平台的介绍 2492700
邀请新用户注册赠送积分活动 2378884